• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模拟退火的癌症中突变驱动通路识别算法

Simulated annealing based algorithm for identifying mutated driver pathways in cancer.

作者信息

Li Hai-Tao, Zhang Yu-Lang, Zheng Chun-Hou, Wang Hong-Qiang

机构信息

College of Information and Communication Technology, Qufu Normal University, Rizhao 276826, China.

College of Jia Sixie Agriculture, Weifang University of Science and Technology, Shouguang 262700, China.

出版信息

Biomed Res Int. 2014;2014:375980. doi: 10.1155/2014/375980. Epub 2014 May 26.

DOI:10.1155/2014/375980
PMID:24982873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4058194/
Abstract

With the development of next-generation DNA sequencing technologies, large-scale cancer genomics projects can be implemented to help researchers to identify driver genes, driver mutations, and driver pathways, which promote cancer proliferation in large numbers of cancer patients. Hence, one of the remaining challenges is to distinguish functional mutations vital for cancer development, and filter out the unfunctional and random "passenger mutations." In this study, we introduce a modified method to solve the so-called maximum weight submatrix problem which is used to identify mutated driver pathways in cancer. The problem is based on two combinatorial properties, that is, coverage and exclusivity. Particularly, we enhance an integrative model which combines gene mutation and expression data. The experimental results on simulated data show that, compared with the other methods, our method is more efficient. Finally, we apply the proposed method on two real biological datasets. The results show that our proposed method is also applicable in real practice.

摘要

随着下一代DNA测序技术的发展,可以实施大规模癌症基因组学项目,以帮助研究人员识别驱动基因、驱动突变和驱动通路,这些因素促使大量癌症患者体内的癌细胞增殖。因此,剩下的挑战之一是区分对癌症发展至关重要的功能性突变,并过滤掉无功能的随机“乘客突变”。在本研究中,我们引入了一种改进方法来解决所谓的最大权重子矩阵问题,该问题用于识别癌症中的突变驱动通路。该问题基于两个组合属性,即覆盖性和排他性。特别地,我们增强了一个整合基因突变和表达数据的模型。在模拟数据上的实验结果表明,与其他方法相比,我们的方法更有效。最后,我们将所提出的方法应用于两个真实的生物学数据集。结果表明,我们提出的方法在实际应用中也是适用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/f33bddad422d/BMRI2014-375980.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/c4850c5ef531/BMRI2014-375980.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/7a9a2f4ba485/BMRI2014-375980.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/cdf9174b0838/BMRI2014-375980.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/69f520664916/BMRI2014-375980.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/bfa0aaaaa464/BMRI2014-375980.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/71ccf309b9d4/BMRI2014-375980.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/9675b8ce1941/BMRI2014-375980.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/f33bddad422d/BMRI2014-375980.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/c4850c5ef531/BMRI2014-375980.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/7a9a2f4ba485/BMRI2014-375980.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/cdf9174b0838/BMRI2014-375980.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/69f520664916/BMRI2014-375980.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/bfa0aaaaa464/BMRI2014-375980.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/71ccf309b9d4/BMRI2014-375980.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/9675b8ce1941/BMRI2014-375980.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2373/4058194/f33bddad422d/BMRI2014-375980.008.jpg

相似文献

1
Simulated annealing based algorithm for identifying mutated driver pathways in cancer.基于模拟退火的癌症中突变驱动通路识别算法
Biomed Res Int. 2014;2014:375980. doi: 10.1155/2014/375980. Epub 2014 May 26.
2
Identifying overlapping mutated driver pathways by constructing gene networks in cancer.通过构建癌症基因网络来识别重叠的突变驱动通路。
BMC Bioinformatics. 2015;16 Suppl 5(Suppl 5):S3. doi: 10.1186/1471-2105-16-S5-S3. Epub 2015 Mar 18.
3
Efficient methods for identifying mutated driver pathways in cancer.高效鉴定癌症中突变驱动途径的方法。
Bioinformatics. 2012 Nov 15;28(22):2940-7. doi: 10.1093/bioinformatics/bts564. Epub 2012 Sep 14.
4
De novo discovery of mutated driver pathways in cancer.癌症中突变驱动途径的从头发现。
Genome Res. 2012 Feb;22(2):375-85. doi: 10.1101/gr.120477.111. Epub 2011 Jun 7.
5
Identification of mutated driver pathways in cancer using a multi-objective optimization model.使用多目标优化模型识别癌症中的突变驱动通路。
Comput Biol Med. 2016 May 1;72:22-9. doi: 10.1016/j.compbiomed.2016.03.002. Epub 2016 Mar 10.
6
Identification of driver pathways in cancer based on combinatorial patterns of somatic gene mutations.基于体细胞基因突变的组合模式识别癌症中的驱动途径。
Neoplasma. 2016;63(1):57-63. doi: 10.4149/neo_2016_007.
7
Identifying mutated driver pathways in cancer by integrating multi-omics data.通过整合多组学数据鉴定癌症中的突变驱动途径。
Comput Biol Chem. 2019 Jun;80:159-167. doi: 10.1016/j.compbiolchem.2019.03.019. Epub 2019 Apr 2.
8
Simultaneous identification of multiple driver pathways in cancer.同时鉴定癌症中的多个驱动途径。
PLoS Comput Biol. 2013;9(5):e1003054. doi: 10.1371/journal.pcbi.1003054. Epub 2013 May 23.
9
The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.癌症中突变驱动途径的发现:模型和算法。
IEEE/ACM Trans Comput Biol Bioinform. 2018 May-Jun;15(3):988-998. doi: 10.1109/TCBB.2016.2640963. Epub 2016 Dec 15.
10
LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.LNDriver:基于基因-基因相互作用网络整合突变和表达数据来识别驱动基因。
BMC Bioinformatics. 2016 Dec 23;17(Suppl 17):467. doi: 10.1186/s12859-016-1332-y.

引用本文的文献

1
Identification of Common Driver Gene Modules and Associations between Cancers through Integrated Network Analysis.通过综合网络分析鉴定常见驱动基因模块及癌症之间的关联
Glob Chall. 2021 Jun 19;5(9):2100006. doi: 10.1002/gch2.202100006. eCollection 2021 Sep.
2
Analysis, identification and visualization of subgroups in genomics.基因组学中的亚组分析、鉴定和可视化。
Brief Bioinform. 2021 May 20;22(3). doi: 10.1093/bib/bbaa217.
3
Prediction of Driver Modules via Balancing Exclusive Coverages of Mutations in Cancer Samples.通过平衡癌症样本中突变的排他性覆盖来预测驱动模块

本文引用的文献

1
Efficient methods for identifying mutated driver pathways in cancer.高效鉴定癌症中突变驱动途径的方法。
Bioinformatics. 2012 Nov 15;28(22):2940-7. doi: 10.1093/bioinformatics/bts564. Epub 2012 Sep 14.
2
De novo discovery of mutated driver pathways in cancer.癌症中突变驱动途径的从头发现。
Genome Res. 2012 Feb;22(2):375-85. doi: 10.1101/gr.120477.111. Epub 2011 Jun 7.
3
Detecting cancer gene networks characterized by recurrent genomic alterations in a population.在人群中检测具有反复发生的基因组改变特征的癌症基因网络。
Adv Sci (Weinh). 2018 Dec 18;6(4):1801384. doi: 10.1002/advs.201801384. eCollection 2019 Feb 20.
4
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer.CoMEt:一种识别癌症中互斥改变组合的统计方法。
Genome Biol. 2015 Aug 8;16(1):160. doi: 10.1186/s13059-015-0700-7.
PLoS One. 2011 Jan 4;6(1):e14437. doi: 10.1371/journal.pone.0014437.
4
Patient-oriented gene set analysis for cancer mutation data.面向患者的癌症基因突变数据基因集分析。
Genome Biol. 2010;11(11):R112. doi: 10.1186/gb-2010-11-11-r112. Epub 2010 Nov 23.
5
Advances in understanding cancer genomes through second-generation sequencing.通过第二代测序技术深入了解癌症基因组。
Nat Rev Genet. 2010 Oct;11(10):685-96. doi: 10.1038/nrg2841.
6
International network of cancer genome projects.国际癌症基因组计划网络。
Nature. 2010 Apr 15;464(7291):993-8. doi: 10.1038/nature08987.
7
Cancer genome sequencing: a review.癌症基因组测序:综述
Hum Mol Genet. 2009 Oct 15;18(R2):R163-8. doi: 10.1093/hmg/ddp396.
8
The GluR2 subunit inhibits proliferation by inactivating Src-MAPK signalling and induces apoptosis by means of caspase 3/6-dependent activation in glioma cells.在胶质瘤细胞中,谷氨酸受体2(GluR2)亚基通过使Src-丝裂原活化蛋白激酶(MAPK)信号失活来抑制增殖,并通过半胱天冬酶3/6依赖性激活诱导细胞凋亡。
Eur J Neurosci. 2009 Jul;30(1):25-34. doi: 10.1111/j.1460-9568.2009.06804.x. Epub 2009 Jun 25.
9
Molecular classification of solid tumours: towards pathway-driven therapeutics.实体瘤的分子分类:迈向通路驱动的治疗方法。
Br J Cancer. 2009 May 19;100(10):1517-22. doi: 10.1038/sj.bjc.6605031. Epub 2009 Apr 14.
10
Utilizing the molecular gateway: the path to personalized cancer management.利用分子通路:个性化癌症管理之路
Clin Chem. 2009 Apr;55(4):684-97. doi: 10.1373/clinchem.2008.118554. Epub 2009 Feb 26.